InterventionsHumans1,011 ckd patientsCohort study

Continuation of sodium-glucose co-transporter 2 inhibitors in advanced chronic kidney disease: a retrospective study with inverse probability of treatment weighting analysis

Graphical abstract from Clinical Kidney Journal — Graphical abstractNg et al.

Clinical Kidney Journal

The paper

Jack Kit‐Chung Ng, Elaine Chow, Winston Wing‐Shing Fung,

Gordon Chun‐Kau Chan, Kai‐Ming Chow,

Cheuk‐Chun Szeto

Chinese University of Hong Kong

Clinical Kidney Journal · 7 Aug 2026

doi.org/10.1093/ckj/sfag260 PubMed 42699509

Drug class linked to fewer deaths or complications in kidney disease
The American Journal of Cardiology · 8 Oct 2026
SGLT2 inhibitors raise genital but not urinary infection risk
Clinical Pharmacology and Therapeutics · 4 Oct 2026
Underweight is linked to higher kidney disease risk in diabetes
Frontiers in Endocrinology · 4 Oct 2026
Lower physical performance links to heart failure and death in CKD
Clinical Journal of the American Society of Nephrology · 4 Oct 2026